A WHO report highlights the seriousness of India's hepatitis challenge. With approximately 3 crore hepatitis B patients and over 50 lakh hepatitis C patients, the country has the 2nd highest burden of these liver diseases in the world.
What is Hepatitis?
- Hepatitis is an inflammation of the liver that is caused by a variety of infectious viruses and noninfectious agents leading to a range of health problems, some of which can be fatal.
- The condition can be short-term (acute) or long-term (chronic) and might progress to liver scarring (cirrhosis) or liver cancer.
- Symptoms: Symptoms of hepatitis A, B and C may include fever, malaise, loss of appetite, diarrhoea, nausea, abdominal discomfort, dark-coloured urine and jaundice (a yellowing of the skin and whites of the eyes). In some cases, the virus can also cause a chronic liver infection that can later develop into cirrhosis (a scarring of the liver) or liver cancer.
- There are 5 main strains of the hepatitis virus, referred to as types A, B, C, D and E. While they all cause liver disease, they differ in important ways including modes of transmission, severity of the illness, geographical distribution and prevention methods.
- In particular, types B and C lead to chronic disease in hundreds of millions of people and together are the most common cause of liver cirrhosis, liver cancer and viral hepatitis-related deaths.
5 Types of Hepatitis Virus
|
Hepatitis A Virus (HAV):
|
- It is the most common type of viral hepatitis.
- Causes: It is generally seen in the areas where sanitation and sewage disposal are poor. It is usually a short-term (acute) infection.
- Transmission: Commonly spread through faecal-oral route (ingestion of contaminated food and water). Certain sex practices can also spread HAV.
- Treatment: There is no specific treatment other than using medication. Vaccines are available to prevent HAV.
|
Hepatitis B Virus (HBV):
|
- Transmission
- Through exposure to infective blood, semen, and other body fluids.
- From infected mothers to infants at the time of birth
- Through contaminated injections during medical procedures, & through injection drug use.
- Prevention: Safe and effective vaccines are available to prevent HBV.
|
Hepatitis C Virus (HCV)
|
- Transmission: Through exposure to infective blood during transfusions of HCV-contaminated blood and blood products, contaminated injections during medical procedures, and through injection drug use. Sexual transmission is also possible but is much less common.
- There is no vaccine for HCV.
|
Hepatitis D Virus (HDV)
|
- It occurs only in those who are infected with HBV.
- The dual infection of HDV and HBV can result in a more serious disease and worse outcome.
- Prevention: Hepatitis B vaccines protect from HDV infection.
|
Hepatitis E Virus (HEV)
|
- Transmission is mostly through the consumption of contaminated water or food.
- Prevention: Safe and effective vaccines to prevent HEV infection have been developed but are not widely available.
|
Facts
- Hepatitis A and E are typically caused by ingestion of contaminated food or water.
- Hepatitis B, C and D usually occur as a result of contact with infected body fluids.
- Hepatitis B and C can cause chronic hepatitis and are responsible for 96% of overall hepatitis mortality.
- Hepatitis A and E cause acute hepatitis.
- Vaccines are available to prevent hepatitis A, B and E. However, no vaccine for hepatitis C.
|
India has several initiatives to combat hepatitis, including:
- National Viral Hepatitis Control Program (NVHCP), which was launched in 2018 in line with Sustainable Development Goal (SDG) 3.3.
- The program aims to eliminate viral hepatitis by 2030.
NVHCP aims to achieve the following:
- Prevention: Raise awareness and provide free diagnosis and treatment
- Eliminate Hepatitis C: Eliminate Hepatitis C by 2030
- Reduce morbidity and mortality: Reduce the morbidity and mortality associated with Hepatitis B and C, such as cirrhosis and liver cancer
- Reduce risk and mortality: Reduce the risk, morbidity, and mortality due to Hepatitis A and E
The NVHCP includes the following components:
- Preventive component
- Diagnosis and Treatment
- Monitoring and Evaluation, Surveillance and Research
- Training and Capacity Building
The program also includes operational guidelines, national laboratory guidelines, and national guidelines for diagnosis and management of viral hepatitis.